Introduction
In 1913 A. Alzheimer wrote a brilliant paper about "dementia praecox", which is now called "schizophrenia". However, there were those before him. In 1884 Meynert published a book called "Psychiatrie". Meynert was from Vienna. Meynert found atrophy of the frontal lobes in what is now called "schizophrenia".
Alzheimer
In 1913 Alzheimer described pigmentary degeneration. This was confirmed by Vogt & Vogt in 1952. The Vogts studied catatonia. They found abnormal neurons in the cingulate and prefrontal cortex. They thought that the diseased cells caused schizophrenic symptoms. Also in 1952 Von Buttlar-Brentano reported similar pathology.
Uranova (1988)
Uranova, is a series of papers that began in 1988, reported "ultrastructural alterations of the prefrontal cortex in schizophrenia. She used the electron microscope. She found the synapses to be abnormal.
Casanova et al (1990)
Casanova et al reported central chromatolysis and gliosis in the brainstem and thalamus. Cell loss, dystrophic neurons, etc. were seen in the frontal lobes, piriform cortex, and entorhinal region. Manuel Casanova, of Augusta, Georgia, suggested "disturbance of dopaminergic neurons" since these areas invlove such neurons.
International Neuropathology Research
There have been numerous positive neuropathology reports in schizophrenia and related diseases. These reports prove Scientology to be wrong. Scientology has accused psychiatry of "junk science and bad medicine". They claim that there is no chemical imbalance. However, neuropathology data supports chemical imbalance theories. It is Scientology itself that is junk science.
In 1975 Fisman of South Africa reported positive findings in the brain stem in "psychosis". He found ventricular diation, atrophy, lipofuscin, glial knots, corpora amylacea, perivascular infiltration, necrosis, cell loss, calcification, neuronophagia, gliosis, sclerosis, iron encrustation, etc. A case with Huntington's chorea showed marked frontal atrophy and atrophy of the caudate nucleus. The patient had been suicidal. Lipofuscin was seen even though death was at 35 years of age. Gliosis and corpora amylacea were seen. Thus the neuropathology picture was similar to that seen in schizophrenia. After this study Fisman moved to Canada.
In 1897 and 1913 Alzheimer published articles on "dementia praecox". These articles were not about the disease that now bears his name. That was discussed in another article. Alzheimer reported cerebral lesions. The lesions and deficit were mainly in the second and third cortical layers. These were small-celled layers. The Vogts described alveolar degeneration, lipoid sclerosis, cellular ballooning, etc. This was reported by C. Vogt and O. Vogt in 1952.
Between 1904 and 1909 Klippel and Lhermitte published reports of cerebral lesions in "dementia praecox", which is now called "schizophrenia". They found progressive atrophy of the pyramidal cells of the fifth and sixth cortical layers with disappearance of Nissl bodies and of neurofibrils. Lipid deposits appeared in the cytoplasm. There was a marked reaction of the neuroglia. There was secondary degeneration of myelin related to the lesions of the pyramidal cells. There were similar lesions in the subcortical nuclei.
Buscaino reported racemose areas formed by metachromatic bodies in the cerebral cortex of schizophrenics. The myelin did not stain with the usual colorants. He attributed this to an abnormal amine (substance X).
Scharenberg & Brown (1954) reported marked alterations in catatonia. They found extensive necrosis with marked reactions of the three types of glia. This appears to suggest an unknown toxic factor. This supports the toxin reported by Buscaino. Although Buscaino published many reports, one appeared in 1958.
Elvidge & Reed reported swelling of the oligodendroglia in both schizophrenia and manic-depressive psychosis. They found hypertrophy of astrocytes. They found a chronic process which suggested a toxic factor of metabolic origin. This was reported in 1938.
Nieto & Escobar used Hortega's lithium-silver carbonate stain for neuroglial impregnation. They found glial prolifation in the diencephalon and mesencephalon. Unfortunately this does not tell us exactly what is happening, but it tells us where it is happening. In particular the hypothalamus was affected. The thalamus was also affected.
Mott found atrophic changes in the hypophysis, an endocrine gland located in the base of the brain.
A Possible Cure for Mental Disease
Since there is a biological cause for schizophrenia, the cure will also be biological. But, unfortunately, this is easier said than done. First one should understand the physiological basis for schizophrenia. Then one should correct the chemical errors. This is the approach of the late Linus Pauling. Unfortunately, Pauling never completely understood the chemical errors.
Buscaino
In 1921 Buscaino used silver nitrate in a test of the urine of schizophrenics. It seems that the urine of a schizophrenic causes a black precipitate, whereas the urine of normals causes a white precipitate. This was later called the "black reaction". In 1922 V. M. Buscaino published his results. Buscaino had previously studied brain pathology in what is now called "schizophrenia". Buscaino reported the presence of substances of the amine type.
Autopsies
Autopsies by various scientists revealed neuronal damage both in the cortex and in the basal ganglia and brainstem. The glia were abnormal. There was metachromatic formations of myelin, areas of hypo and demyelinization, etc. In 1921 V. M. Buscaino reported "clods of disintegration in clusters". These were limited ovoidal or bullet-shaped swellings with a granular or amorphous content. In 1964 Pecchiai reported confirmation of this work. The material was glyco-lipidic. This suggests deposits of carbohydrate and fat. But what could cause this? If excessive amino acids flooded the cells, some of these amino acids would be converted to fat.
Dysmetabolism
The cure may involve correcting the dysmetabolism. Carbohydrate deposits could occur if the cells burned amino acids instead of carbohydrates. Thus the cure, or treatment, could be a diet low in fat and low in amino acids.
Conclusions
The whole picture is extremely complicated, unfortunately. However, there is a great deal of data, which is good. Making sense of this data is difficult but important. Kraepelin analyzed Alzheimer's data and compared it to the work of others in 1913. Kraepelin felt that it was valid. The disappearance of the Nissl bodies, reported by French workers and German workers, could be explained if amino acids were flooding the cells. This would also explain the lipid eposits reported by Klippel & Lhermitte.
The gliosis reported by the Mexican workers and others supports a toxic factor theory. According to Buscaino, this toxic factor is an amine. Hopf reported lipofuscin deposits in 1952, which was a banner year for this type of research. The lipofuscin could either be a toxic factor itself or represent residue from the toxic amine or both. Amines can sometimes end up as neuromelanin (as in the case of dopamine), which looks like lipofuscin. It could be that an abnormal amine produces an abnormal type of neuromelanin. The abnormal amine could cause the cells to be flooded with amino acids, explaining much of the data.
If all of this is true, it would appear that a therapy could be a diet very low in amino acids. The Vogts found that the cellular structures slowly disintegrate. This probably means that the whole cell is affected. The first structure to go is the Nissl bodies, which house amino acids. The Mexican workers felt that stress was involved. They were probably correct. Stress might cause the release of the toxin.
Casanova's "disturbance of dopaminergic neurons" seems to support the late Dr. Friedhoff's biochemical theory. Friedhoff found a toxin, DMPEA, which was produced from dopamine. DMPEA was found only in schizophrenics.








Comments: 9
The group: We Comment Back
6: Related Articles, LinksVenkatasubramanian G.
Antipsychotic-induced weight gain in patients with schizophrenia.
JAMA. 2008 Apr 23;299(16):1899; author reply 1899-900. No abstract available.
PMID: 18430906 [PubMed - indexed for MEDLINE]
7: Related Articles, LinksLlewellyn DJ, Naughton F.
Antipsychotic-induced weight gain in patients with schizophrenia.
JAMA. 2008 Apr 23;299(16):1898-9; author reply 1899-900. No abstract available.
PMID: 18430905 [PubMed - indexed for MEDLINE]
25: Related Articles, LinksLeo R, Razzini C, Di Lorenzo G, Bianchi F, Tesauro M, Zanasi M, Siracusano A, Romeo F.
Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
J Clin Psychiatry. 2008 Feb;69(2):327-8. No abstract available.
31: Related Articles, LinksRodríguez-García E, Oscariz-Collar L.
[Atrioventricular block induced by high-dose risperidone]
Farm Hosp. 2007 Nov-Dec;31(6):385-7. Spanish. No abstract available.
40: Related Articles, LinksInada T, Koga M, Ishiguro H, Horiuchi Y, Syu A, Yoshio T, Takahashi N, Ozaki N, Arinami T.
Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
52: Related Articles, LinksPoyurovsky M, Weizman R, Weizman A.
Aripiprazole's receptor pharmacology and extrapyramidal side effects.
Am J Psychiatry. 2008 Mar;165(3):398; author reply 398-9. No abstract available.
53: Related Articles, LinksHazra M, Mamo DC, Remington G.
Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects.
Am J Psychiatry. 2008 Mar;165(3):396-7; author reply 397-8. No abstract available.
56: Related Articles, LinksSaid Q, Gutterman EM, Kim MS, Firth SD, Whitehead R, Brixner D.
Somnolence effects of antipsychotic medications and the risk of unintentional injury.
Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):354-64.
57: Related Articles, LinksLin YC, Chen HZ, Chang TJ, Lane HY.
Hypokalemia following rapid titration of quetiapine treatment.
J Clin Psychiatry. 2008 Jan;69(1):165-6. No abstract available.
This is only the tip of the iceberg. The next time you complain I will throw more drug side effect information at you. Hypokalemia means that potassium is too low in the blood.
what did the guy above mean with his, and I quote, "IF I would have given such a lame "thesis" to a college professor, not only would I have gotten an F, but I bet that you would have been laughed at. finish quote ?
"If I would have" is not correct English usage .......and if he gave the paper to his professor, why would you be laughed at? If the professor laughed, would it be because he gave it or because of the content? Why you when he would have been the one presenting the paper?
I think the information is good to know. There is so much about the brain that is misunderstood or not understood to any degree. There is much More to learn about it than has been learned.
I gave you a ten.
There is a theory that statin drugs can cause memory loss. Have you taken statins?
Looks like Ed feels that your theories are not complete nor do they offer a final analysis - how can they when Alzheimers is still being researched.